Conventional stage | TNM stage | Clinical Manifestations | Treatment | Fifteen Year Survival (%) |
A1 | T1a | Non palpable tumor, low grade cancer, <5% of prostate involved (Incidental finding at prostatectomy) | Observation | Normal |
A2 | T1b | Non palpable tumor, high grade cancer or >5% of prostate involved, or both (Incidental finding at prostatectomy) | Total prostatectomy with pelvic lymphadenectomy | 30 - 45 |
B1 | T2a | Localized nodule, 1 - 1.5 cm in diameter in one lobe | Total prostatectomy with pelvic lymphadenectomy | 50 - 60 |
B2 | T2b | Tumor > 1.5 cm in diameter or more than one lobe | Total prostatectomy with pelvic lymphadenectomy | 35 - 45 |
C | T3, T4 | Periprostatic extension | Radiation with or without pelvic lymphadenectomy | 20 - 30 |
D | N+ Or M+ | Pelvic lymph node involvement or distant metastasis | Hormonal therapy (LHRH/antiandrogen) when symptomatic. Irradiation for isolated bone pain | 0 - 10 |